Background Transcatheter aortic valve replacement (TAVR) has emerged as a treatment
option for severe aortic stenosis in patients at intermediate or high surgical risk. However …

Importance Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to
surgical aortic valve replacement and is the treatment of choice for patients at high operative …

Aims In view of the currently available evidence from randomized trials, we aimed to
compare the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) …

The aim of this article is to capture the session at EuroPCR 2017 covering the SURTAVI
study, communicate the analysis of the trialists, and report the views expressed in the …

Abstract On August 16, 2019, the US Food and Drug Administration approved expanding the
indication for transcatheter aortic valve replacement (TAVR) to low-risk patients with …

Surgical aortic valve replacement (SAVR) is currently the standard of care to treat patients
with severe symptomatic aortic stenosis (AS) and is generally accepted to alleviate …

aortic valve replacement (TAVR) has revolutionized the therapeutic management of
symptomatic patients with severe aortic stenosis (AS). First, TAVR offers a lifesaving option …

Initially restricted to high-risk and inoperable patients with symptomatic severe aortic
stenosis (AS), transcatheter aortic valve replacement (TAVR) is increasingly being offered to …

Abstract Background: Transcatheter Aortic Valve Implantation (TAVI) is an emerging
alternative to medical therapy reserved to a limited population with severe aortic stenosis …

Background: Transcatheter aortic valve replacement (TAVR) is an option in certain high-risk
surgical patients with severe aortic valve stenosis. It is unknown whether TAVR can be …